Cyclopentasiloxane vs Partially Hydrogenated Oils: which is worse?
Quick answer: Partially Hydrogenated Oils carries the heavier risk profile. Cyclopentasiloxane is restricted in the EU and allowed in the US; Partially Hydrogenated Oils is — in the EU and — in the US.
| Property | Cyclopentasiloxane | Partially Hydrogenated Oils |
|---|---|---|
| EU status | Restricted | — |
| US status | Allowed | — |
| Risk level | medium | — |
| Banned in | — | United States (FDA revoked GRAS status 2015; compliance deadline June 2018; manufacturing effectively banned), European Union (banned 2021 — maximum 2g trans fat per 100g total fat), Canada (banned 2018), United Kingdom, Denmark (first country to ban, 2003) |
| Restricted in | European Union | — |
| Category | endocrine disruptor | additive |
| Where it hides | hair serum, primer, deodorant | — |
What is Cyclopentasiloxane?
Cyclopentasiloxane is a volatile silicone (D5) used for smooth, silky texture.
What is Partially Hydrogenated Oils?
Partially hydrogenated oils (PHOs) are vegetable oils that have been treated with hydrogen gas in the presence of a catalyst to make them semi-solid at room temperature. This process creates artificial trans fatty acids (trans fats) as a byproduct. They were developed in the early 20th century as a cheaper, longer-lasting alternative to lard and butter.
Documented risks
Cyclopentasiloxane: Persistent and bioaccumulative; the EU restricts D5 in wash-off products over environmental and endocrine concerns. The US has no restriction.
Partially Hydrogenated Oils: Artificial trans fats (from PHOs) have the most well-established cardiovascular harm of any food ingredient ever banned. Multiple large meta-analyses have confirmed that trans fat consumption increases LDL ('bad') cholesterol, decreases HDL ('good') cholesterol, increases inflammatory markers, and significantly raises cardiovascular disease risk. The Harvard Nurses' Health Study and other landmark prospective studies in the 1990s identified trans fat as uniquely harmful — worse than saturated fat in its cardiovascular effects. A 2006 NEJM meta-analysis by Mozaffarian et al. estimated that eliminating artificial trans fats from the US diet could prevent 72,000 to 228,000 heart attacks per year and 30,000 to 100,000 coronary heart disease deaths annually. The WHO estimates that industrially produced trans fats cause over 500,000 cardiovascular deaths per year globally. The FDA revoked PHOs' GRAS status in 2015 based on this evidence, with compliance by 2018. Denmark banned artificial trans fats in 2003, the first country to do so, and observed a dramatic reduction in cardiovascular mortality in subsequent years.
Scan a barcode and we'll flag both Cyclopentasiloxane and Partially Hydrogenated Oils (plus 200+ other ingredients banned overseas).
Scan free →